Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.

Oncotarget - 22 Sept 2015

Yu Ke-Da, Wang Xin, Yang Chen, Zeng Xiao-Hua, Shao Zhi-Ming

Abstract excerpt

PURPOSE: Chemokines may play vital roles in breast cancer progression and metastasis. The primary members of chemokine decoy receptors (CDR), DARC and D6, are expressed in breast tumors and lymphatic/hematogenous vessels. CDRs sequestrate the pro-malignant chemokines. We hypothesized that breast...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemokine CCL2
Share to Chemokine CCL5
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Duffy Blood-Group System

Share to Kaplan-Meier Estimate

Share to Neoplasm Recurrence, Local

Share to Proportional Hazards Models

Share to Receptors, Chemokine

Source

Open in PubMed Open full text

Identifiers

PMID: 26314842
DOI: 10.18632/oncotarget.4470
PMCID: PMC4694919

Genes

CCL2
CCL5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26314842-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.PMID 26314842Read ↗

Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer.Semantic proximity Read ↗

Cooperation of DLC1 and CDK6 affects breast cancer clinical outcome.Semantic proximity Read ↗

Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness.Semantic proximity Read ↗

The African-Specific Variant in the Duffy Antigen Receptor for Chemokines Gene, CD8+ T-Cell Density, and Aggressive Breast Cancer Subtypes in Black Women.Semantic proximity Read ↗

Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma.Semantic proximity Read ↗

Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer.Semantic proximity Read ↗

Correlation between Duffy blood group phenotype and breast cancer incidence.Semantic proximity Read ↗

The impact of the stromal cell-derived factor-1-3'A and E-selectin S128R polymorphisms on breast cancer.Semantic proximity Read ↗

Breast Cancer Progression and Host Polymorphisms in the Chemokine System: Role of the Macrophage Chemoattractant Protein-1 (MCP-1) −2518 G AlleleSemantic proximity Read ↗

Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer.Semantic proximity Read ↗

The β-Chemokine Receptor D6 Is Expressed by Lymphatic Endothelium and a Subset of Vascular TumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.